We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
PE is an accurate glycogenomics editing technology based on the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system and it does not need exogenous donor DNA and DNA double-strand breaks (DSBs). PE depends on the "search" and "replacement" of target sequences. nCas9 with single-strand cleavage activity was blended into M-MLV-RT and targeted to a specific site mediated by prime editing guide RNA (pegRNA) in the PE system. Then, the single strand at the target site is cleaved and nicked by the effector protein, and reverse transcription begins dependent on the reverse transcription template (RTT) in the pegRNA. Next, the edited DNA sequence is integrated into the complementary strand by the DNA repair mechanism, and the edited DNA is further copied into the other strand, resulting in a stable edited DNA sequence.
Fig.1 Schematic diagram of the operating principle based on the prime editing system. (Huang & Liu, 2023)
PE is the most practical of the editing tools due to its high efficiency in a two-plasmid system comprising a nickase Cas9-RT fusion and a pegRNA plasmid.
Fig.2 PE experiment procedure. (CD BioGlyco)
CD BioGlyco has been committed to Glycogenomics research for many years and has accumulated rich practical experience. Please feel free to contact us for more information about genetic research.
References:
About Us
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy